Farther Finance Advisors’s Rhythm Pharmaceuticals RYTM Stock Holding History

Farther Finance Advisors’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$72.5K	Buy	653 +8	+1%	+$723	﹤0.01%	2953
2026 Q1	$56.8K	Buy	645 +3	+0.5%	+$292	﹤0.01%	2903
2025 Q4	$68.7K	Buy	642 +291	+83%	+$30.9K	﹤0.01%	2598
2025 Q3	$35.4K	Buy	351 +322	+1,110%	+$29.9K	﹤0.01%	2652
2025 Q2	$1.83K	Buy	29 +15	+107%	+$918	﹤0.01%	3730
2025 Q1	$700	Hold	14	–	–	﹤0.01%	3709
2024 Q4	$784	Hold	14	–	–	﹤0.01%	3325
2024 Q3	$733	Buy	14 +5	+56%	+$240	﹤0.01%	3326
2024 Q2	$384	Hold	9	–	–	﹤0.01%	3333
2024 Q1	$384	Hold	9	–	–	﹤0.01%	3098
2023 Q4	$414	Buy	+9	New	+$284	﹤0.01%	3031
2023 Q2	–	Sell	-3,812	Closed	-$68K	–	2557
2023 Q1	$68K	Hold	3,812	–	–	0.02%	518
2022 Q4	$111K	Buy	+3,812	New	+$98K	0.04%	303

Other funds holding RYTM

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

WCM

Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

YIH

Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1.02B AUM 28.36% 1-Year Est. Return

EOJOAM

E. Ohman J:or Asset Management Stockholm, Sweden $4.3B AUM 29.55% 1-Year Est. Return

AWM

Avior Wealth Management Omaha, Nebraska $3.8B AUM 23.28% 1-Year Est. Return

PSP Research Newtown Square, Pennsylvania $188M AUM

EWP

Elevation Wealth Partners Santa Rosa, California $334M AUM 26.48% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Farther Finance Advisors's RYTM Position: Q2 2026 in Review

Farther Finance Advisors increased its Rhythm Pharmaceuticals (RYTM) stake by 1.2% in Q2 2026, buying an estimated $723 and bringing the position to 653 shares worth $72.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2953.

Farther Finance Advisors first reported a position in RYTM in Q4 2022 and has held it in 13 quarters since. The position peaked at $111K in Q4 2022. 20 funds tracked by Wall St. Rank hold RYTM as of Q2 2026.

Farther Finance Advisors held 653 shares of Rhythm Pharmaceuticals worth $72.5K as of Q2 2026.
Farther Finance Advisors bought 8 Rhythm Pharmaceuticals shares in Q2 2026, an estimated $723.
Rhythm Pharmaceuticals made up ﹤0.01% of Farther Finance Advisors's portfolio in Q2 2026, its #2953 holding.
Farther Finance Advisors first reported a position in Rhythm Pharmaceuticals in Q4 2022 and has held it in 13 quarters since.
Farther Finance Advisors's Rhythm Pharmaceuticals position peaked at $111K in Q4 2022.
20 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q2 2026.

Based on Farther Finance Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.